Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of Alabama at Birmingham (IRB#: 300003882; date of initial approval: 28 October 2019) and registered within ClinicalTrials.gov (NCT04132219).